Supplementary table 1. Original data from Yuji Kohara's in situ database (http://nematode.lab.nig.ac.jp). |
|
Expr10187
|
Expressed in g2 glands. |
|
|
|
Expr10176
|
|
|
|
|
Expr10175
|
|
|
Picture: Fig 3. |
|
Expr8677
|
Expression in the alimentary canal: Strong and consistent expression in anterior arcades, posterior arcades. Weak or rare expression in pm2, pm3, pm4, pm5, pm6, pm7, pm8, mc1, g1, g2, rectal gland cells, rectal epithelial cells. Expression in the nervous system: Phsh, AVK, DVC (early larva), PVR, SIB (early larva), URB, I3. Expression in the reproductive system: In adult stage, expressed in gonad sheath, uterus, vulval muscle. In developing larva stage, expressed in vulva. Neuronal expression of inx-9 appears around three-fold stage. The rectal gland expresses inx-9 during early larval stages. inx-9 is expressed in adult hermaphrodite sex muscles. inx-9 was expressed at high levels in arcade cells starting around two-fold stage continuing throughout development and adulthood. |
|
Picture: Fig 3. |
|
Expr8671
|
Expression in the alimentary canal: Strong and consistent expression in pharyngeal epithelium, pm5, pm6, pm7, pm8, g2, rectal gland cells. Weak or rare expression in anterior arcades, posterior arcades, pm2, pm3, pm4, M3, MC, intestine, rectal epithelial cells. Expression in the nervous system: CEPsh, ALN, ASn, CAN, DAn, DBn, DDn, DVA, DVB, HSN, PDE, PLM, PVQ, PVR, PVT, URB, VAn, VBn, VDn, M3, MC. Expression in the reproductive system: In adult stage, expressed in spermatheca, vulval muscle, HSN. In developing larva stage, expressed in vulval muscle, uterine muscle, HSN. inx-3 was expressed broadly during early embryogenesis. After the beginning of morphogenesis, inx-3 expression becomes more restricted to the pharynx, hypodermis, and intestine. By three-fold stage inx-3 expression appears in ventral cord motor neurons (strongest in DA neurons) along with continued strong pharyngeal expression. By hatching, its hypodermal expression disappears, while postembryonically born ventral cord motor neurons express it at low levels. Its pharyngeal (strong) and neuronal (faint) expressions continue to adulthood. |
|
Picture: N.A. |
|
Expr8675
|
Expression in the alimentary canal: Strong and consistent expression in pm5, MC. Weak or rare expression in pharyngeal epithelium, pm1, pm2, pm3, pm4 pm6, pm7, pm8, g1, g2, rectal gland cells. Expression in the nervous system: ADE, AIY, ALM, ALN, AVA, AVK, AVM, BDU, CAN, DAn, DVA, DVB, DVC, FLP, HSN, LUA, PLM, PLN, PVC, PVM, PVP, PVQ, PVT, PVW, RID, RIS, SDQ, URB, MC. Expression in the reproductive system: In adult stage, expressed in HSN. Faint hypodermal expression of inx-7 is seen around two-fold stage and becomes stronger by threefold stage. |
|
Picture: Fig 3. |
|
Expr8679
|
Expression in the alimentary canal: Strong and consistent expression in anterior arcades, posterior arcades, pharyngeal epithelium, pm4, pm8, g1, g2, vir, K.a/K' cells. inx-11 is more strongly expressed in the most posterior (int 9) intestinal cell. Weak or rare expression in pm1, pm2, pm3, pm5, pm6, pm7. Expression in the nervous system: CEPsh, DVC, LUA. Expression in the reproductive system: In adult stage, expressed in utse. In developing larva stage, expressed in uterus, sperm (spermatocytes, spermatids). Expression of inx-11 appears in pharyngeal tissue around two-fold stage, and by three-fold stage, strong expression becomes restricted to g1, g2, pm4, and pm8. inx-11 is expressed in the hypodermal cells of the animal in postembryonic stages. |
|
CeE/Da = hlh-2 in the article. |
|
Expr1470
|
CeE/DA can first be detected in both nuclei of 2-cell embryos. Staining persists apparently in all nuclei of the early embryo for the first 150-200 minutes of development (100-200 cells). By 270 minutes of development (approx. 350 cells) a dramatic change in antibody staining has occurred in which persistent staining is seen in progressively fewer blastomeres. Most, but not all, blastomeres that initially retain CeE/DA antibody staining at this stage are neurons or their immediate precursors. There are a few neuronal precursors that are located away from the neuronal clusters in the embryo (for example the postembryonic neuroblast W), for which antibody staining was not detected. Therefore, although persistent antibody staining is largely restricted to neurons or their precursors, not every such cell is antibody-positive. CeE/DA-antibody staining is transient for the majority of these cells, with the staining progressively lost as differentiation and morphogenesis occur. This is most clearly evident at the 1.5-fold stage of embryogenesis, in which a lateral view of the embryo shows staining in the head, ventral nerve cord and tail. As the embryo begins elongating, the level of CeE/DA-antibody staining decreases in these cells. Note that most of these cells are postmitotic. Although the majority of cells lose CeE/DA-antibody staining during the later half of embryogenesis, a small percentage of cells remain antibody-positive through the remainder of embryogenesis and after hatching. There are 14 of these continually staining cells in the head and seven more in the tail region. Of the 14 head cells, 5 are pharyngeal. The pharyngeal nuclei have been identified, as two pharyngeal muscle nuclei (pm5L and R) and three pharyngeal gland cell nuclei (g1P, g2L and R). The remaining nine CeE/DA antibody-positive cells in the head are outside of the pharynx and are located in the neuronal cluster between the nerve ring and the posterior pharyngeal bulb. There are four bilateral pairs of stained nuclei and one positive nucleus lying along the ventral mid-line. Using hlh-2::GFP reporter strains and DiI staining, three of the bilateral pairs of neurons have been identified as ADL (L and R) and ASH (L and R) and RIC (L and R). The large number of neurons in this area makes it difficult to identify unambiguously each of the remaining three CeE/DA antibody-positive cells. The seven tail cells with nuclei that remain CeE/DA antibody-positive throughout embryonic development include the two Q neuroblasts and five cells were tentatively identified as DVA (an interneuron), the bilateral pair of intestinal muscle cells, the anal depressor muscle and the anal sphincter muscle. The two intestinal and two anal muscle cells are postmitotic and are non-striated muscles. CeE/Da is not detected in bodywall muscles. In addition to the 21 cells that are CeE/DA antibody-positive at hatching, there are several additional cells detected immunologically during subsequent development. One prominent set of cells that becomes CeE/DA antibody-positive during the L3 stage are the 16 developing vulval and uterine muscle cells (non-striated). These nuclei remain antibody-positive in the mature vulva, although staining intensity appears to decrease. Another prominent pair of postembryonic, CeE/DA antibody-positive nuclei are the distal tip cells (DTC). The DTC nuclei are CeE/DA antibody-positive from the start of gonad elongation in larval development and remain positive in adulthood. Very faint antibody staining can also be detected in the syncytial gonad. |
At all developmental stages, CeE/DA antibody staining is nuclear (except in the germline). |
Picture: N.A. |
|
Expr8692
|
Expression in the alimentary canal: Weak or rare expression in posterior arcades, g1, g2. Expression in the nervous system: AIN, AVA, AVB, AVD, AVG, AVK, DDn (3-fold to early larva), DVA, DVB, DVC, IL1, OLL, PVD, PVQ, PVT, RIV, RME, RMG, SDQ, SIA, SIB, SMB, VCn. Expression in the reproductive system: In adult stage, expressed in VCn. In developing larva stage, expressed in VCn. |
|
|
|
Expr2005
|
Expression is generally confined to the g1 and g2 pharyngeal gland cells, both within the nuclei of these cells, and more weakly throughout the cytoplasm and processes of these cells. Expression is seen predominantly in older larvae and adults, but is occasionally seen in young larvae. Weak expression in the larval and adult intestine is also occasionally seen. |
Expressed in nuclei, more weakly throughout the cytoplasm and processes of pharyngeal gland cells. |
Picture: Fig. 4. |
|
Expr9161
|
Transgenic animals expressing nlr-1prom::gfp showed strong fluorescence in pharyngeal g1 and g2 gland cells, pharyngeal muscle cells and the unilateral, GABAergic RIS interneuron. These are the only cells in which strong and consistent expression is observed. Expression was observed during all stages of larval development and adulthood. |
|
|
|
Expr10163
|
|
|
Reporter gene fusion type not specified. |
|
Expr10164
|
|
|
|
|
Expr10165
|
|
|
|
|
Expr10166
|
Reporter gene fusion type not specified. |
|
Reporter gene fusion type not specified. |
|
Expr10168
|
|
|
|
|
Expr10169
|
|
|
|
|
Expr10170
|
|
|
|
|
Expr10171
|
|
|
|
|
Expr10172
|
|
|
|
|
Expr10173
|
|
|
|
|
Expr10174
|
|
|
Reporter gene fusion type not specified. |
|
Expr10177
|
|
|
|
|
Expr11794
|
|
|
|
|
Expr1783
|
Specific expression observed only in a cellular process, probably the secretory network of the G2 gland cells. Signal appeared in the embryo as soon as pharyngeal structures could be discerned and remained through adulthood. |
|